UC San Diego Moores Cancer Center — La Jolla, California

Public research footprint of UC San Diego Moores Cancer Center, compiled from the ClinicalTrials.gov public registry.

427

Registered studies

222

Active

Recruiting now

109

Completed

Stopped or withdrawn

Most-studied conditions

Malignant Solid Neoplasm · Metastatic Non-Cutaneous Melanoma · Stage IB Lung Non-Small Cell Carcinoma AJCC v7 · Recurrent Astrocytoma, IDH-Mutant, Grade 3

Recently updated registry entries

NCT03775265 — Chemoradiotherapy With or Without Atezolizumab in Treating Patients With Localized Muscle… (Active Not Recruiting)
NCT03528642 — Telaglenastat With Radiation Therapy and Temozolomide in Treating Patients With… (Active Not Recruiting)
NCT00977574 — Paclitaxel, Carboplatin, and Bevacizumab or Paclitaxel, Carboplatin, and Temsirolimus or… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at UC San Diego Moores Cancer Center?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.